A

AixThera

Europe, Dublin, Ireland, Dublin

Description

AixThera was formed to invest in the development of new therapeutics with the potential to positively impact patient lives.

Investor Profile

AixThera has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AixThera frequently co-invest with?

BACKED VC
Europe, England, United Kingdom, London
Co-Investments: 1
H
Asia, T'ai-wan, Taiwan, Hsinchu
Co-Investments: 1
EIT Health
Europe, Bayern, Germany, Munich
Co-Investments: 1
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 1
Selvedge Venture
Europe, England, United Kingdom, London
Co-Investments: 1
LifeLink Ventures
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does AixThera often collaborate with?

AZ
North America, California, United States, San Francisco
Shared Deals: 1
KF
North America, California, United States, San Francisco
Shared Deals: 1
MC
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by AixThera?

Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AOct 10, 2022
Amount Raised: $30,000,000